SCHEMBL2494993

SCHEMBL2494993

CCCCNc1ccc(-c2ccc(C)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.61
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.41
HRH3 Q9Y5N1 3/20 0.41
LMNA P02545 2/20 0.41
SCN5A Q14524 2/20 0.41
CYP1A2 P05177 1/20 0.41
MAOA P21397 1/20 0.41
CNR1 P21554 1/20 0.41
DRD4 P21917 1/20 0.41
ACHE P22303 1/20 0.41
HRH2 P25021 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
MAPK1 P28482 1/20 0.41
NTSR1 P30989 1/20 0.41
HRH1 P35367 1/20 0.41
DRD3 P35462 1/20 0.41
SCN1A P35498 1/20 0.41
HTR2B P41595 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20692502 0.94 MAPT (0.59) MAPTHTTHRH3PLK1ALDH1A1
SCHEMBL1485752 0.94 MAPT (0.70) MAPTHPGDHTTHRH3LMNA
SCHEMBL18722580 0.92 MAPT (0.57) MAPTHTTHRH3ACHEPLK1
SCHEMBL17225159 0.92 MAPT (0.57) MAPTHTTHRH3ACHEPLK1
SCHEMBL30800856 0.92 MAPT (0.46) MAPTHRH3LMNASCN5ACYP1A2
SCHEMBL2256877 0.88 MAPT (0.67) MAPTHTTHRH3PLK1ALDH1A1
SCHEMBL2492357 0.88 MAPT (0.67) MAPTHPGDHTTHRH3LMNA
SCHEMBL18779741 0.86 MAPT (0.50) MAPTHPGDHRH3LMNASCN5A
SCHEMBL3678588 0.86 MAPT (0.64) MAPTHTTPLK1ABL1
SCHEMBL11324887 0.86 MAPT (0.64) MAPTHTTPLK1ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH MAPT 3454/4885HPGD 1749/4885HTT 1217/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 MAPT 3294/4885HPGD 1563/4885HTT 946/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R MAPT 3128/4885HPGD 1618/4885HTT 989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.